Define benefit hypotheses for computational biology, evidence-integration, and AI/ML capabilities.
Develop KPIs and baselines covering time from data to insight, data-preparation effort, workflow reproducibility, data reuse, target confidence, evidence quality, target-prioritization lead time, and access to genetics, omics, clinical, and real-world evidence data.
Define benefit-measurement methods, data sources, and benefit owners.
Develop the quantified In Silico benefits case and prepare investment decision materials.
Build implementation roadmaps, manage dependencies, and support RAID management and program governance.
Prepare Gate and steering committee materials.
Combine scientific, technical, and commercial considerations into coherent recommendations for senior decision-makers.
Requirements
5+ years of experience in business analysis, strategy, or program delivery in life sciences, biotech, data, or AI/ML transformation environments.
A relevant degree in life sciences, computational biology, bioinformatics, or a related scientific discipline.
Experience in benefits modelling for data, analytics, AI, or R&D transformation programs — including quantified business cases, KPI definition, baseline setting, and benefit-measurement approaches.
Ability to assess and quantify improvements across productivity, lead time, quality, capacity, and decision confidence in a research or drug discovery context.
Experience developing implementation roadmaps, managing dependencies, and supporting RAID management, program governance, and Gate preparation.
Experience preparing investment decision materials for senior or executive audiences.
Proven ability to combine scientific, technical, and commercial considerations into a coherent recommendation.
Strong executive communication, analytical, and presentation skills.